Vijayakumar, Vishwaarth
Joshi, Tanvi
Elkhadragy, Lobna
Schook, Lawrence B.
Gaba, Ron C.
El-Kebir, Mohammed
Schachtschneider, Kyle M.
Article History
Received: 14 June 2024
Accepted: 25 April 2025
First Online: 8 May 2025
Declarations
:
: Institutional Animal Care and Use Committee approval was obtained at two institutions: University of Illinois at Urbana-Champaign with protocol #16–065 (approved on 06/23/2016) and University of Illinois at Chicago with protocol #16–090 (approved on 07/13/2016). Humane care was provided to all animals under the criteria described in the Guide for the Care and Use of Laboratory Animals.
: Not applicable.
: L.B.S. and K.M.S. works for Sus Clinicals, which provides the Oncopig and other pig-based preclinical testing services to customers. L. B. S., L. E., and K.M.S. also reports funding support from the NIH/NCI. L.B.S. reports grants from Guerbet USA LLC, Janssen Research & Development LLC, TriSalus Life Sciences, and Early Inc. L. E. and L.B.S. also reports funding support from the Society of Interventional Radiology. R.C.G. reports funding support from the NIH, Guerbet USA LLC, Janssen Research & Development LLC, NeoTherma Oncology, TriSalus Life Sciences, and Sus Clinicals. R.C.G. also reports consulting fees from the Boston Consulting Group, a provisional patent, and stock options from Sus Clinicals. R.C.G. reports being on the advisory boards of Sus Clinicals and Clinical Events Committee.